Start here · since 1996

Psychedelics Guide

More than 500 articles organized by substance and topic: psilocybin, LSD, ayahuasca, DMT, MDMA, mescaline and harm reduction. Rigorous information, without fear and without propaganda.

Featured articles

Explore the largest archive on psychoactive substances, published since 1996

US Psychedelic Helpline: Insights from 25,419 Interactions

A Science Advances paper details 25,419 contacts with the Fireside Project (2021-2026), primarily regarding psilocybin and trip support. Among interactions with recorded history, 2.4% mentioned schizophrenia. The data reflects only those who reached out.

Persistent difficulties after psychedelics or meditation: Emory publishes a protocol for a 1,600-person study

A team led by Emory University has posted on medRxiv the protocol for an observational study that will follow, for one year, people who attribute persistent difficulties to psychedelics or meditation. It is a research plan with no data. The sample is deliberately recruited among affected people, so it is not designed to estimate how often these problems occur.

Mind & Spirit

Inspiring reads for open minds

From our readers

Articles chosen by our community of readers

Send us your story and get featured on our homepage

Amphetamines: History, Pharmacology, and Risks of a Stimulant

Synthetic derivatives of ephedrine, these drugs appeared in US pharmacies around 1930 as a way to keep patients awake after sedative overdoses. Shortly after, they were launched as inhalers for colds and nasal congestion, later as pills for motion sickness and obesity, and finally as antidepressants. Following amphetamine itself (Benzedrine, Sympatina, Profamina, Centramina, etc.), its isomer dexamphetamine (Dexedrine) appeared, and in 1938, methamphetamine (Methedrine).

Pleasure and Risk: A New Approach to Drug Education

The sixth installment of Sustainable Hedonism proposes informing, treating, and researching drug use by acknowledging both its risks and its pleasures.

Hofmann, Huxley, and Jünger: The Session That Named the Psychonaut

This continues our article "LSD—Completely Personal,"* based on a lecture Albert Hofmann delivered at the 1996 Worlds of Consciousness Conference in Heidelberg, Germany. Hofmann discusses his relationship with Aldous Huxley and begins to recount his encounters with Ernst Jünger, one of the most significant 20th-century German writers and the creator of the term "psychonaut."

LSD, the Medicine of Dr. Albert Hofmann

DESOXY: The Shulgin Account of Emotional Blunting

We revisit Ann Shulgin’s experience with DESOXY: a rare case of affective flattening and cold detachment, viewed through a harm reduction lens.

Salvia divinorum: Legal Status in Spain and Worldwide

What the law says about Salvia divinorum: banned from sale in Spain since 2004, a fragmented global landscape, and why the EMA and AEMPS do not endorse it.

News

The latest from the psychedelic world

Latest articles

Browse our most recent articles